L-NAME reverses quinolinic acid-induced toxicity in rat corticostriatal slices: Involvement of src family kinases

Journal of Neuroscience Research

Volumn 85, Issue 12, 2007, Pages 2770-2777

  Mallozzi, Cinzia ^a   Martire, Alberto ^a   Domenici, Maria Rosaria ^a   Metere, Alessio ^a   Popoli, Patrizia ^a   Di Stasi, A M Michela ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

NO (nitric oxide); Oxidative stress; Protein tyrosine kinases; Protein tyrosine phosphatases; Striatum

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; QUINOLINIC ACID; REACTIVE OXYGEN METABOLITE;

ANIMAL TISSUE; BRAIN SLICE; CONFERENCE PAPER; CONTROLLED STUDY; DEPRESSION; DRUG MECHANISM; ENZYME ACTIVITY; MALE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION;

ACTION POTENTIALS; ANIMALS; CORPUS STRIATUM; DRUG INTERACTIONS; ENZYME INHIBITORS; MALE; NEUROTOXINS; NG-NITROARGININE METHYL ESTER; PHOSPHOTYROSINE; QUINOLINIC ACID; RATS; RATS, WISTAR; SRC-FAMILY KINASES; SYNAPTOSOMES;

EID: 34548363867     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21178     Document Type: Conference Paper

References (48)

1. Aarts M, Liu Y, Liu L, Besshoh S, Arundine M, Gurd JW, Wang YT, Salter MW, Tymianski M. 2002. Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions. Science 298:846-850.
2. Abe J, Berk BC. 1999. Fyn and JAK2 mediate Ras activation by reactive oxygen species. J Biol Chem 274:21003-21010.
3. Ali DW, Salter MW. 2001. NMDA receptor regulation by Src kinase signalling in excitatory synaptic transmission and plasticity. Curr Opin Neurobiol 11:336-342.
4. Anderson WW, Collingridge GL. 2001. The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events. J Neurosci Methods 108:71-83.
5. Beal MF, Kowall NW, Ellison DW, Mazurek MF, Swartz KJ, Martin JB. 1986. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321:168-171.
6. Chiarugi P, Cirri P. 2003. Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction. Trends Biochem Sci 28:509-514.
7. Christopherson KS, Hillier BJ, Lim WA, Bredt DS. 1999. PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J Biol Chem 274:27467-27473.
8. den Hertog J, Groen A, van der Wijk T. 2005. Redox regulation of protein-tyrosine phosphatases. Arch Biochem Biophys 434:11-15.
9. Espey MG, Tang Y, Morse HC, 3rd, Moffett JR, Namboodiri MA. 1996. Localization of quinolinic acid in the murine AIDS model of retrovirus-induced immunodeficiency: implications for neurotoxicity and dendritic cell immunopathogenesis. AIDS 10:151-158.
10. Ferrante RJ, Kowall NW, Cipolloni PB, Storey E, Beal MF. 1993. Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization. Exp Neurol 119:46-71.
11. Foster AC, Collins JF, Schwarcz R. 1983. On the excitotoxic properties of quinolinic acid, 2,3-piperidine dicarboxylic acids and structurally related compounds. Neuropharmacology 22:1331-1342.
12. Garthwaite J. 1991. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 14:60-67.
13. Goda K, Kishimoto R, Shimizu S, Hamane Y, Ueda M. 1996. Quinolinic acid and active oxygens. Possible contribution of active oxygens during cell death in the brain. Adv Exp Med Biol 398:247-254.
14. Heyes MP, Mefford IN, Quearry BJ, Dedhia M, Lackner A. 1990. Increased ratio of quinolinic acid to kynurenic acid in cerebrospinal fluid of D retrovirus-infected rhesus macaques: relationship to clinical and viral status. Ann Neurol 27:666-675.
15. Huttner WB, Schiebler W, Greengard P, De Camilli P. 1983. Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation. J Cell Biol 96:1374-1388.
16. Kalia LV, Salter MW. 2003. Interactions between Src family protein tyrosine kinases and PSD-95. Neuropharmacology 45:720-728.
17. Kalia LV, Gingrich JR, Salter MW. 2004. Src in synaptic transmission and plasticity. Oncogene 23:8007-8016.
18. Kashii S, Mandai M, Kikuchi M, Honda Y, Tamura Y, Kaneda K, Akaike A. 1996. Dual actions of nitric oxide in N-methyl-D-aspartate receptor-mediated neurotoxicity in cultured retinal neurons. Brain Res 711:93-101.
19. Klotz LO, Schieke SM, Sies H, Holbrook NJ. 2000. Peroxynitrite activates the phosphoinositide 3-kinase/Akt pathway in human skin primary fibroblasts. Biochem J 352:219-225.
20. Le HT, Maksumova L, Wang J, Pallen CJ. 2006. Reduced NMDA receptor tyrosine phosphorylation in PTPalpha-deficient mouse synaptosomes is accompanied by inhibition of four src family kinases and Pyk2: an upstream role for PTPalpha in NMDA receptor regulation. J Neurochem 98:1798-1809.
21. Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HS, Sucher NJ, Loscalzo J, Singel DJ, Stamler JS. 1993. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364:626-632.
22. Lipton SA, Stamler JS. 1994. Actions of redox-related congeners of nitric oxide at the NMDA receptor. Neuropharmacology 33:1229-1233.
23. Mallozzi C, Di Stasi AM, Minetti M. 1997. Peroxynitrite modulates tyrosine-dependent signal transduction pathway of human erythrocyte band 3. FASEB J 11:1281-1290.
24. Metere A, Mallozzi C, Minetti M, Domenici MR, Pezzola A, Popoli P, Di Stasi AM. 2006. Quinolinic acid modulates the activity of src family kinases in rat striatum: in vivo and in vitro studies. J Neurochem 97:1327-1336.
25. Minetti M, Mallozzi C, Di Stasi AM. 2002. Peroxynitrite activates kinases of the src family and upregulates tyrosine phosphorylation signaling. Free Radic Biol Med 33:744-754.
26. Moroni F, Lombardi G, Carla V, Pellegrini D, Carassale GL, Cortesini C. 1986. Content of quinolinic acid and of other tryptophan metabolites increases in brain regions of rats used as experimental models of hepatic encephalopathy. J Neurochem 46:869-874.
27. Nakashima I, Kato M, Akhand AA, Suzuki H, Takeda K, Hossain K, Kawamoto Y. 2002. Redox-linked signal transduction pathways for protein tyrosine kinase activation. Antioxid Redox Signal 4:517-531.
28. Nakashima I, Takeda K, Kawamoto Y, Okuno Y, Kato M, Suzuki H. 2005. Redox control of catalytic activities of membrane-associated protein tyrosine kinases. Arch Biochem Biophys 434:3-10.
29. Ogawa T, Matson WR, Beal MF, Myers RH, Bird ED, Milbury P, Saso S. 1992. Kynurenine pathway abnormalities in Parkinson's disease. Neurology 42:1702-1706.
30. Pelkey KA, Askalan R, Paul S, Kalia LV, Nguyen TH, Pitcher GM, Salter MW, Lombroso PJ. 2002. Tyrosine phosphatase STEP is a tonic brake on induction of long-term potentiation. Neuron 34:127-138.
31. Perez-Severiano F, Escalante B, Rios C. 1998. Nitric oxide synthase inhibition prevents acute quinolinate-induced striatal neurotoxicity. Neurochem Res 23:1297-1302.
32. Ponniah S, Wang DZ, Lim KL, Pallen CJ. 1999. Targeted disruption of the tyrosine phosphatase PTPalpha leads to constitutive downregulation of the kinases Src and Fyn. Curr Biol 9:535-538.
33. Popoli P, Pintor A, Domenici MR, Frank C, Tebano MT, Pezzola A, Scarchilli L, Quarta D, Reggio R, Malchiodi-Albedi F, Falchi M, Massotti M. 2002. Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum. J Neurosci 22:1967-1975.
34. Popoli P, Pintor A, Tebano MT, Frank C, Pepponi R, Nazzicone V, Grieco R, Pezzola A, Reggio R, Minghetti L, De Berardinis MA, Martire A, Potenza RL, Domenici MR, Massotti M. 2004. Neuroprotective effects of the mGlu5R antagonist MPEP towards quinolinic acid-induced striatal toxicity: involvement of pre- and post-synaptic mechanisms and lack of direct NMDA blocking activity. J Neurochem 89:1479-1489.
35. Pu M, Akhand AA, Kato M, Hamaguchi M, Koike T, Iwata H, Sabe H, Suzuki H, Nakashima I. 1996. Evidence of a novel redox-linked activation mechanism for the Src kinase which is independent of tyrosine 527-mediated regulation. Oncogene 13:2615-2622.
36. Rubbo H, Radi R, Trujillo M, Telleri R, Kalyanaraman B, Barnes S, Kirk M, Freeman BA. 1994. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem 269:26066-26075.
37. Sala C, Sheng M. 1999. The fyn art of N-methyl-D-aspartate receptor phosphorylation. Proc Natl Acad Sci U S A 96:335-337.
38. Santamaria A, Rios C. 1993. MK-801, an N-methyl-D-aspartate receptor antagonist, blocks quinolinic acid-induced lipid peroxidation in rat corpus striatum. Neurosci Lett 159:51-54.
39. Santamaria A, Galvan-Arzate S, Lisy V, Ali SF, Duhart HM, Osorio-Rico L, Rios C, St'astny F. 2001. Quinolinic acid induces oxidative stress in rat brain synaptosomes. Neuroreport 12:871-874.
40. Santamaria D, Espinoza-Gonzalez V, Rios C, Santamaria A. 1999. Nomega-nitro-L-arginine, a nitric oxide synthase inhibitor, antagonizes quinolinic acid-induced neurotoxicity and oxidative stress in rat striatal slices. Neurochem Res 24:843-848.
41. Santiago-Lopez D, Vazquez-Roman B, Perez-de La Cruz V, Barrera D, Rembao D, Salinas-Lara C, Pedraza-Chaverri J, Galvan-Arzate S, Ali SF, Santamaria A. 2004. Peroxynitrite decomposition catalyst, iron metalloporphyrin, reduces quinolinate-induced neurotoxicity in rats. Synapse 54:233-238.
42. Schwarcz R, Foster AC, French ED, Whetsell WO Jr, Kohler C. 1984. Excitotoxic models for neurodegenerative disorders. Life Sci 35:19-32.
43. Snyder SH. 1993. Janus faces of nitric oxide. Nature 364:577.
44. Stone TW. 1993. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev 45:309-379.
45. Takagi N, Logan R, Teves L, Wallace MC, Gurd JW. 2000. Altered interaction between PSD-95 and the NMDA receptor following transient global ischemia. J Neurochem 74:169-178.
46. Tebano MT, Domenici MR, Popoli P. 2002. SCH 58261 differentially influences quinolinic acid-induced effects in striatal and in hippocampal slices. Eur J Pharmacol 450:253-257.
47. Tezuka T, Umemori H, Akiyama T, Nakanishi S, Yamamoto T. 1999. PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A. Proc Natl Acad Sci U S A 96:435-440.
48. Zheng XM, Wang Y, Pallen CJ. 1992. Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase. Nature 359:336-339.